Answers are grounded in this paper and cite their sources.
India’s ministry of health and family welfare has revoked the ban that it placed on the antidiabetes drug pioglitazone just six weeks ago because of the drug’s association with bladder cancer.1 The Drug Technical Advisory Board, through the Gazette of India , recommended revoking the ban after reviewing the evidence, and imposed various conditions for the use of pioglitazone.2 It recommends, for example, that pioglitazone should not be used as a first line treatment for diabetes. The ban and the subsequent reversal of the policy have caused a media storm in India, …
No takes yet. Share an insight, caveat, or question.
Soumyadeep Bhaumik (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: